Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116985152 | 11698515 | 2 | F | 20150819 | 20160621 | 20151104 | 20160701 | EXP | DE-FRI-1000080598 | FOREST | 82.00 | YR | M | Y | 0.00000 | 20160701 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116985152 | 11698515 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | Y | 20822 | 10 | MG | ||||||||
| 116985152 | 11698515 | 2 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | Y | 20822 | 20 | MG | ||||||||
| 116985152 | 11698515 | 3 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 100 | MG | |||||||||
| 116985152 | 11698515 | 4 | C | BISOPROLOL | BISOPROLOL | 1 | Oral | 0 | 2.5 | MG | |||||||||
| 116985152 | 11698515 | 5 | C | JODID | IODINE | 1 | Oral | 0 | 200 | MG | |||||||||
| 116985152 | 11698515 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 1000 | MG | |||||||||
| 116985152 | 11698515 | 7 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 100 | MG | |||||||||
| 116985152 | 11698515 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 20 | MG | |||||||||
| 116985152 | 11698515 | 9 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | |||||||||
| 116985152 | 11698515 | 10 | C | XARELTO | RIVAROXABAN | 1 | Oral | 0 | 20 | MCI | |||||||||
| 116985152 | 11698515 | 11 | C | CALCIUM | CALCIUM | 1 | Oral | 500 MILLIGRAM | 0 | 1 | DF | ||||||||
| 116985152 | 11698515 | 12 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | 0 | 2 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116985152 | 11698515 | 1 | Depressive symptom |
| 116985152 | 11698515 | 3 | Analgesic therapy |
| 116985152 | 11698515 | 4 | Hypertension |
| 116985152 | 11698515 | 5 | Thyroiditis |
| 116985152 | 11698515 | 6 | Diabetes mellitus |
| 116985152 | 11698515 | 7 | Gout |
| 116985152 | 11698515 | 8 | Hyperlipidaemia |
| 116985152 | 11698515 | 9 | Gastrointestinal disorder |
| 116985152 | 11698515 | 10 | Anticoagulant therapy |
| 116985152 | 11698515 | 11 | Mineral supplementation |
| 116985152 | 11698515 | 12 | Laxative supportive care |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116985152 | 11698515 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116985152 | 11698515 | Drug ineffective | |
| 116985152 | 11698515 | Dystonia | |
| 116985152 | 11698515 | Headache | |
| 116985152 | 11698515 | Parkinsonism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116985152 | 11698515 | 1 | 20150601 | 20150730 | 0 | |
| 116985152 | 11698515 | 2 | 20150731 | 20150825 | 0 |